Search

Your search keyword '"Chiò, Adriano"' showing total 1,434 results

Search Constraints

Start Over You searched for: Author "Chiò, Adriano" Remove constraint Author: "Chiò, Adriano"
1,434 results on '"Chiò, Adriano"'

Search Results

2. iDPP@CLEF 2024: The Intelligent Disease Progression Prediction Challenge

4. Predictors for progression in amyotrophic lateral sclerosis associated to SOD1 mutation: insight from two population-based registries

7. Safety and efficacy of arimoclomol in patients with early amyotrophic lateral sclerosis (ORARIALS-01): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial

8. Genome-wide structural variant analysis identifies risk loci for non-Alzheimer’s dementias

9. Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

10. Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2023

11. Dealing with Data Scarcity in Rare Diseases: Dynamic Bayesian Networks and Transfer Learning to Develop Prognostic Models of Amyotrophic Lateral Sclerosis

12. iDPP@CLEF 2023: The Intelligent Disease Progression Prediction Challenge

16. Factors predicting disease progression in C9ORF72 ALS patients

17. Pathogenic Huntingtin Repeat Expansions in Patients with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis

18. Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review

19. The contribution of Neanderthal introgression and natural selection to neurodegenerative diseases

21. Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2022

22. Whole genome sequencing analysis reveals post-zygotic mutation variability in monozygotic twins discordant for amyotrophic lateral sclerosis

28. Use of the combination of spirometry, arterial blood gas analysis and overnight oximetry to predict the outcomes of patients affected by motor neuron disease: The Milan‐Torin respiratory score (Mi‐To‐RS)

29. High Frequency of Cognitive and Behavioral Impairment in Amyotrophic Lateral Sclerosis Patients with SOD1 Pathogenic Variants

30. Sex Differences in Amyotrophic Lateral Sclerosis Survival and Progression: A Multidimensional Analysis

31. Hereditary motor sensory neuropathy with proximal involvement (HMSN‐P) associated with TFG p.Pro285Leu variant in an Italian family with a motor neuron disease‐like clinical picture

32. Distinct neural signatures of pulvinar in C9orf72 amyotrophic lateral sclerosis mutation carriers and noncarriers

33. European Academy of Neurology (EAN) guideline on the management of amyotrophic lateral sclerosis in collaboration with European Reference Network for Neuromuscular Diseases (ERNEURO‐NMD)

35. Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trial

38. Identifying and predicting amyotrophic lateral sclerosis clinical subgroups: a population-based machine-learning study

43. Calculated Maximal Volume Ventilation (cMVV) as a Marker of Early Respiratory Failure in Amyotrophic Lateral Sclerosis (ALS)

45. Resting‐state fMRI functional connectome of C9orf72 mutation status

46. Safety and efficacy of oral levosimendan in people with amyotrophic lateral sclerosis (the REFALS study): a randomised, double-blind, placebo-controlled phase 3 trial

50. Genome sequencing analysis identifies new loci associated with Lewy body dementia and provides insights into its genetic architecture

Catalog

Books, media, physical & digital resources